Cerevel Therapeutics

Cerevel Therapeutics

Pharmaceutical Manufacturing

Cambridge, Massachusetts 24,928 followers

We are a biopharmaceutical company focused on unraveling the mysteries of the brain to treat neuroscience diseases.

About us

Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson’s, Alzheimer’s, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.

Website
https://www.cerevel.com
Industry
Pharmaceutical Manufacturing
Company size
201-500 employees
Headquarters
Cambridge, Massachusetts
Type
Public Company
Founded
2018

Locations

  • Primary

    222 Jacobs Street, Suite 200

    Suite 200

    Cambridge, Massachusetts 02141, US

    Get directions

Employees at Cerevel Therapeutics

Updates

Similar pages

Browse jobs

Funding

Cerevel Therapeutics 6 total rounds

Last Round

Post IPO equity

US$ 450.0M

See more info on crunchbase